TFG-001 Shows Enhanced Reinnervation and Functionality in Parkinson’s Disease

TFG-001 Shows Enhanced Reinnervation and Functionality in Parkinson’s Disease. https://www.magnific.com/free-photo/cancer-patient-hospital-medium-shot_33754019.htm#fromView=search&page=1&position=3&uuid=0a9dcb68-58b2-49de-98f7-9658d22ae627&query=TFG-001+Shows+Enhanced+Reinnervation+and+Functionality+in+Parkinson%E2%80%99s+Disease

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, on May 25th announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as […]

MTF Biologics Collaborates with Kolosis BIO to Boost DBX Brand

MTF Biologics Expands DBX Distribution with Kolosis BIO (Photo: Business Wire)

MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, has expanded its strategic agreement with Kolosis BIO (Kolosis), a leading provider of orthobiologics solutions. As part of this collaboration, Kolosis has grown the portfolio of MTF Biologics allograft solutions it represents and distributes to […]